Published in J Neurol on December 02, 2014
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50
EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep (1992) 11.58
Molecular biology of prion diseases. Science (1991) 10.83
The FAB: a Frontal Assessment Battery at bedside. Neurology (2000) 8.93
Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology (2004) 2.15
Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med (1986) 1.73
Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet (1990) 1.27
Prion diseases. J Neurol Neurosurg Psychiatry (2004) 1.20
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cerebrospinal Fluid Res (2008) 1.17
Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews. Medicine (Baltimore) (1997) 1.14
MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol (2008) 1.04
Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 0.98
Demyelinating peripheral neuropathy in Creutzfeldt-Jakob disease. Muscle Nerve (1992) 0.93
Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain (2009) 0.93
Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. Neurology (2002) 0.91
Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200(Lys) mutation. Neurology (1996) 0.89
Creutzfeldt-Jakob disease among Libyan Jews. Eur J Epidemiol (1991) 0.87
Fatal familial insomnia and the role of the thalamus in sleep regulation. Handb Clin Neurol (2011) 0.87
The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression. Acta Neurol Scand (2011) 0.86
Creutzfeldt-Jakob disease: a disease overview. Am J Electroneurodiagnostic Technol (2008) 0.84
Characterization of movement disorders in patients with familial Creutzfeldt-Jakob disease carrying the E200K mutation. Isr Med Assoc J (2012) 0.80
Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology. J Neurol (2010) 0.78
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (2012) 2.98
A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Genet (2008) 2.58
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings. Ann Neurol (2012) 2.33
X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet (2008) 1.95
Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain (2008) 1.94
Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev (2009) 1.93
PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet (2012) 1.91
CSF biomarker variability in the Alzheimer's Association quality control program. Alzheimers Dement (2013) 1.90
Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet (2003) 1.65
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Exp Neurol (2010) 1.61
Multiple sclerosis frequency in Israel's diverse populations. Neurology (2006) 1.52
Aquaporin 4 molecular mimicry and implications for neuromyelitis optica. J Neuroimmunol (2013) 1.42
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg (2011) 1.42
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel. Isr Med Assoc J (2005) 1.41
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Isr Med Assoc J (2004) 1.39
Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum (2007) 1.27
Computer-based, personalized cognitive training versus classical computer games: a randomized double-blind prospective trial of cognitive stimulation. Neuroepidemiology (2011) 1.26
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model. Neurobiol Dis (2009) 1.26
Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord (2007) 1.26
Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum (2007) 1.19
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa. Mov Disord (2006) 1.13
Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med (2012) 1.12
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Mov Disord (2007) 1.11
White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS. Magn Reson Imaging (2005) 1.09
Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol (2012) 1.08
The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation. Magn Reson Imaging (2006) 1.07
Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J Neuropathol Exp Neurol (2009) 1.04
Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J Physiol (2002) 1.03
The influence of odorants on respiratory patterns in sleep. Chem Senses (2009) 1.01
Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med (2015) 1.00
Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol (2005) 1.00
Use of the virtual action planning supermarket for the diagnosis of mild cognitive impairment: a preliminary study. Dement Geriatr Cogn Disord (2009) 0.98
Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia (2004) 0.98
Sexual dysfunction in Parkinson's disease. J Sex Marital Ther (2004) 0.98
Smoking and tea consumption delay onset of Parkinson's disease. Parkinsonism Relat Disord (2008) 0.97
Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord (2010) 0.97
TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells. Immunobiology (2009) 0.97
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol (2010) 0.96
The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice. Prog Neurobiol (2002) 0.96
Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol (2004) 0.96
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis. Brain Struct Funct (2012) 0.95
Web-based multi-center data management system for clinical neuroscience research. J Med Syst (2010) 0.94
Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review. Clin Rev Allergy Immunol (2010) 0.94
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int J Geriatr Psychiatry (2010) 0.94
Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease. Cogn Behav Neurol (2007) 0.94
Broad phenotypic heterogeneity due to a novel SCN1A mutation in a family with genetic epilepsy with febrile seizures plus. J Child Neurol (2013) 0.93
Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice. Neurobiol Dis (2003) 0.93
Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain (2009) 0.93
TBC1D24 mutation associated with focal epilepsy, cognitive impairment and a distinctive cerebro-cerebellar malformation. Epilepsy Res (2013) 0.92
Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth? Ann N Y Acad Sci (2009) 0.92
Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice. BMC Med (2013) 0.92
Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. J Neurol (2003) 0.91
Homocysteine, stroke, and dementia. Stroke (2002) 0.91
Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. Immunobiology (2009) 0.90
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis. PLoS One (2013) 0.89
Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation. Exp Neurol (2013) 0.88
MRI detection of the cerebellar syndrome in Creutzfeldt-Jakob disease. Cerebellum (2009) 0.88
Changes in axonal morphology in experimental autoimmune neuritis as studied by high b-value q-space (1)H and (2)H DQF diffusion magnetic resonance spectroscopy. Magn Reson Med (2002) 0.88
Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging (2008) 0.88
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One (2013) 0.88
Human-computer interaction in the administration and analysis of neuropsychological tests. Comput Methods Programs Biomed (2004) 0.88
Early onset dementia: clinical and social aspects. Int Psychogeriatr (2009) 0.87
The herbal preparation Padma® 28 protects against neurotoxicity in PC12 cells. Phytother Res (2011) 0.87
Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease. Neurochem Int (2007) 0.87
The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. Parkinsonism Relat Disord (2007) 0.87
Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis. Auton Neurosci (2011) 0.87
Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background. Neurobiol Aging (2009) 0.86
Quantitative detection of thrombin activity in an ischemic stroke model. J Mol Neurosci (2013) 0.86
Predictors for poststroke outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) study protocol. Int J Stroke (2011) 0.86
Thrombin regulation of synaptic plasticity: implications for physiology and pathology. Exp Neurol (2013) 0.86
Analysis of genetic polymorphisms in acetylcholinesterase as reflected in different populations. Curr Alzheimer Res (2005) 0.86
Ischemic stroke due to acute basilar artery occlusion: proportion and outcomes. Isr Med Assoc J (2010) 0.85
A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping. Brain (2005) 0.85
Gender effect on time to levodopa-induced dyskinesias. J Neurol (2011) 0.85
Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Dis (2008) 0.85
Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression). J Autoimmun (2008) 0.85
Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus. Ann N Y Acad Sci (2010) 0.84
Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Clin Neuropharmacol (2006) 0.84
Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease? J Neural Transm (Vienna) (2010) 0.84
Computerized diagnosis of mild cognitive impairment. Alzheimers Dement (2007) 0.84
Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. Parkinsonism Relat Disord (2012) 0.84
Gender differences in lay persons' beliefs and knowledge about Alzheimer's disease (AD): a national representative study of Israeli adults. Arch Gerontol Geriatr (2012) 0.84
Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity (2007) 0.83
Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci (2004) 0.83